FDA Investigator Gina C Collins
Gina C Collins has conducted inspections on 52 sites in 1 countries as of 10 Dec 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
52
Last Inspection Date:
10 Dec 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gina C Collins:
Aaron J Poloni,
Abby M Miller,
Alexander M Kay,
Alicia Aborg Borm,
Alicia M Weitzel,
Andrew K Haack, PhD,
Belinda E Clifton,
Brandon R Boone,
Brenda K Alford,
Bruce R Burrell,
Bryan Baker,
Camille Bennett Hoffman,
Celeta S Coves,
Christopher R Czajka,
Christopher S Genther,
Clint R Van Blaricom,
Connie P Rezendes,
Dan C Fisher,
Dan G Eisenbrey,
David A Quale,
Dennis R Hudson,
Dianne B Latona,
Dirk L Lincoln,
Dolores E Price,
Donald B Mckechnie,
Donald W Jehn,
Edward D Harris,
Emanual A Kahsai,
Eric C Keane,
Eric C Milstead,
Erica Fernandez,
Erica R Mahone,
Gavin W Pierce,
Gloria J Baca, MS,
Hanna L Potter,
Harmon M Blanch,
Heika R Tait,
James E Trabert,
James S Cartwright,
James S Lo,
Janice Wai,
Jason W Cornell,
Jean Brewer,
Jeanne M Weishaar,
Jeffery A Johnson,
Jeffrey C Moncalieri,
Jennifer J Edmiston,
Jeremy R Read,
Jessica B Clark,
Jessica L Diliberti,
Jessica L Walters Moell,
Jinkee Mvila Binayug,
John T Sproul,
Jonathan T Little,
Joseph A Seitz, III,
Joseph M Hudak,
Julian C Hanson,
Kaarin M Slotte,
Karla J Youngberg,
Katharine Chan,
Katherine L Arnold,
Kathryn A Krentz,
Kevin T Gerrity,
Kimberly A Dux,
Kimberly L Wheeler,
Lauren E Swantko,
LCDR Ismael Olvera, IV,
Lee Terry Moore,
Lenita R Silvera,
Leon R Marquart,
Lesley A Swanson,
Lisa A Bowden,
Lisa K Capron,
Lisa M Althar,
Lori J Jennings,
LT Mark A Chen, MPH,
LTJG Bradley E Benasutti,
Marcus A Goshen,
Margo C Jones,
Maria Pkelly Doggett, MBA,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark W Babbitt,
Marlene L Davis,
Marsha L Mccauley,
Melody M Ragasa Leong,
Michael J Donovan,
Mikel T Wright,
Miles D Foster,
Paul M Chefor,
Paul M Kawamoto,
Peter Kessler, PhD,
Peter T Regan,
Rachelle M Deskins,
Rebecca T Davis,
Richard A Martin,
Richard G Runyon,
Richard L Bartlett,
Richard T Riggie,
Robert B Shibuya, MD,
Robert J Vezzetti,
Rocco C Black,
Ronald E Gill,
Ronald P Boyce,
Sana A Elassar,
Sangeeta M Khurana, PhD,
Sarah J Cullen,
Scott Reynolds,
Scott W Fox,
Sharon K Finley,
Shelagh D Schopen,
Stephanie A Jameson,
Steven B Chiu,
Sunitha K Rajaram, PhD,
Sunny R Muir,
Thomas C Mclean, CFS,
Timothy S Williamson,
Tracy K Li,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Victoria V Bot,
Vitaliy N Guyvan,
Wayne D Stowell,
Young M Yoon,
Zachary P Wachlarowicz
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more